台股 » 個股 » 智擎 » 籌碼相關 » 融資融券與借券

智擎

(4162)
可現股當沖
  • 股價
    73.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    634
  • 產業
    上櫃 生技醫療類股
  • 307人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智擎 (4162) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

智擎 (4162) 融資融券與借券

智擎 (4162) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
12/1953,1428.63030.01000.1730.00%634
12/18-73,1378.61030.01000.1731.11%466
12/17-233,1448.63030.01000.172.21.26%464
12/1623,1678.7-230.01000.0971.30.42%219
12/1523,1658.69050.01000.16710.85%273
12/12-1223,1638.69250.01000.1670.4-2.63%818
12/11333,2859.02030.01000.0972.3-0.55%487
12/10203,2528.93030.01000.0972.7-1.49%393
12/09-563,2328.87030.01000.0973.82.36%896
12/08333,2889.03030.01000.0972.1-0.69%388
12/05453,2558.94-130.01000.0972.6-0.68%392
12/0433,2108.81040.01000.1273.10.83%175
12/03-323,2078.81040.01000.1272.5-1.23%374
12/02-193,2398.89040.01000.1273.42.37%755
12/0103,2588.95040.01000.1271.7-0.97%335
11/28243,2588.95-140.01000.1272.4-0.41%267
11/27-43,2348.88050.01000.1572.7-0.55%295
11/26273,2388.89050.01000.1573.10.41%606
11/25323,2118.82050.0120.410.1672.80.41%484
11/24203,1798.73150.01000.1672.54.02%821
11/21-13,1598.67-940.01000.1369.7-3.33%654
11/2023,1608.68-1130.0410.20.4172.12.27%492
11/19-1113,1588.6710140.04000.4470.5-3.16%1,139
11/18323,2698.98040.0110.080.1272.82.39%1,317
11/17-313,2378.89-140.01000.1271.1-1.25%464
11/14623,2688.97050.01000.15720.00%622
11/13113,2068.8050.01000.16720.14%485
11/12-243,1958.77-450.01000.1671.94.96%1,035
11/11-73,2198.84090.02000.2868.50.15%288
11/10-33,2268.86090.02000.2868.40.59%403
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
12/1900003@Limit20.012910-892,611730.00%634
12/1800003@Limit20.015390-342,700731.11%466
12/1700003@Limit20.0116590-432,73472.21.26%464
12/16200-23@Limit20.0112150-32,77771.30.42%219
12/1500005@Limit20.013600362,780710.85%273
12/1202025@Limit20.011921760162,74470.4-2.63%818
12/1100003@Limit20.0124910-672,72872.3-0.55%487
12/1000003@Limit20.013528072,79572.7-1.49%393
12/0900003@Limit20.0132012,78873.82.36%896
12/0800003@Limit20.0128760-482,78772.1-0.69%388
12/05100-13@Limit20.0110550-452,83572.6-0.68%392
12/0400004@Limit20.0180082,88073.10.83%175
12/0300004@Limit20.0140600-202,87272.5-1.23%374
12/0200004@Limit20.0125350-102,89273.42.37%755
12/0100004@Limit20.014070332,90271.7-0.97%335
11/28100-14@Limit20.0112190-72,86972.4-0.41%267
11/2700005@Limit20.0137970-602,87672.7-0.55%295
11/2600005@Limit20.0130032,93673.10.41%606
11/2500005@Limit20.0116460-302,93372.80.41%484
11/2401015@Limit20.019130-42,96372.54.02%821
11/21900-94@Limit20.015647092,96769.7-3.33%654
11/20100-113@Limit20.0431140172,95872.12.27%492
11/1901001014@Limit20.0469390302,94170.5-3.16%1,139
11/1800004@Limit20.0172390332,91172.82.39%1,317
11/17100-14@Limit20.01452220-1772,87871.1-1.25%464
11/1400005@Limit20.01142130-1993,055720.00%622
11/1311005@Limit20.0119720-533,254720.14%485
11/12510-45@Limit20.01122080-1963,30771.94.96%1,035
11/1100009@Limit20.02780-13,50368.50.15%288
11/1000009@Limit20.0257220353,50468.40.59%403
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
12/19392,856,8002,862,5006.15146.15
12/18483,483,1003,481,90010.3-25
12/17694,965,6004,976,60014.87159.42
12/16604,253,0004,262,20027.4153.33
12/15533,743,1003,747,80019.4188.68
12/1214610,418,80010,386,60017.85-220.55
12/1120414,789,10014,796,70041.8937.25
12/10634,608,6004,612,80016.0366.67
12/0917012,438,10012,461,40018.97137.06
12/08936,792,1006,794,40023.9724.73
12/051097,949,4007,960,50027.81101.83
12/04402,900,0002,904,40022.86110
12/03946,842,7006,850,00025.1377.66
12/0220214,810,60014,828,40026.7588.12
12/01745,298,8005,304,30022.0974.32
11/28705,094,1005,099,00026.2270
11/27815,881,8005,886,80027.4661.73
11/2618913,892,90013,876,70031.19-85.71
11/2520614,880,90014,898,50042.5685.44
11/2420414,661,40014,756,60024.85466.67
11/2118012,699,70012,670,40027.52-162.78
11/2014310,218,30010,262,30029.07307.69
11/1950536,569,60036,478,30044.34-180.79
11/1843831,859,40031,872,30033.2629.45
11/171228,689,5008,718,60026.29238.52
11/141198,584,5008,605,20019.13173.95
11/1316611,800,20011,840,10034.23240.36
11/121339,375,1009,477,00012.85766.17
11/11503,440,8003,437,10017.36-74
11/101409,506,1009,535,40034.74209.29
〈焦點股〉智擎胰腺癌新藥獲健保給付 股價強攻半年線Anue鉅亨-2025/11/18
智擎研發中新藥 獲澳洲HERC同意進行一期實體腫瘤人體試驗Anue鉅亨-2025/07/23
智擎 相關文章